Anxiolytic research
An anxiolytic peptide studied for stress reduction without the sedation or cognitive dulling of conventional options.
Selank is a synthetic analog of tuftsin, a naturally occurring immune-modulating peptide, engineered for stability. It is studied primarily as an anxiolytic — something that reduces anxiety — and the reason it draws interest is the specific way it does so, which appears to avoid the trade-offs that make conventional anxiolytics difficult to use during a working day.
Selank enhances GABA signaling — the brain's primary calming system — but binds at a different site than benzodiazepines do. That distinction is the whole point: it appears to produce the calm without the sedation, memory impairment, dependence, or rebound that make benzodiazepines a poor daily tool.
Selank potentiates GABA-A receptor function without occupying the benzodiazepine binding site, which accounts for anxiolysis in the absence of sedation or cognitive impairment. It normalizes serotonin and dopamine metabolism under stress conditions and upregulates BDNF, supporting neuroplasticity. It also inhibits enkephalin-degrading enzymes, raising endogenous opioid tone and stress resilience, and shifts cytokine balance from pro- to anti-inflammatory (lowering IL-6 and TNF-α while raising IL-10). Intranasal or subcutaneous administration; plasma half-life is short while central effects persist for hours.
Effects begin within roughly 15–30 minutes and the calming window runs a few hours. Most people describe it as a lowering of reactivity rather than a mood change — the same stressors, less amplitude. It does not feel like a drug, which is why some users conclude it does nothing until they notice how a difficult week went.
Every page on this site includes this section. If a source only tells you what something does, you are reading marketing.
Tolerability in published use is good, with no dependence or withdrawal syndrome reported — a meaningful contrast with benzodiazepines. Not FDA- or EMA-approved. Anyone taking SSRIs, SNRIs, or other psychiatric medication should involve their prescriber given the serotonergic overlap. Not appropriate during pregnancy or breastfeeding, or for minors.
As with Semax, purity is functionally visible — third-party tested product with a batch-matched certificate of analysis, cold-shipped and cold-stored.
No dependence or withdrawal has been reported in published use, which is the primary reason it attracts interest as an alternative to benzodiazepines. It is not FDA-approved and long-term human data is limited.
It is not expected to. The mechanism was specifically of interest because it separates anxiolysis from sedation.
They are commonly discussed as a pair because they address opposite problems — drive and calm. Whether that combination is appropriate for you is a conversation to have with a provider.
General education only goes so far. If you want help deciding whether this is relevant to your goals, history, and current labs, schedule a consultation with the Bearing team.
Request a Consultation